Cerenome (CNSY) vs Retractable Technologies (RVP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Retractable Technologies (RVP) has outperformed Cerenome (CNSY) over the past year, losing 28.0% versus a loss of 90.5%. Over five years, RVP leads with a -92.8% price change compared with -99.7% for CNSY. Retractable Technologies is the larger company by market cap ($19.9 million vs $14.6 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNSY | RVP |
|---|---|---|
| Share price | $1.93 | $0.6632 |
| Market cap | $14.65M | $19.85M |
| 1-day change | +7.82% | +0.18% |
| YTD return | -85.96% | -14.03% |
| 1-year return | -90.45% | -28.04% |
| 5-year return | -99.73% | -92.76% |
| EPS (TTM) | $-3.36 | $-0.12 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.00 | $1.14 |
| 52-week low | $1.49 | $0.60 |
| Distance from 52-week high | -89.84% | -41.82% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +1337.82% | — |
| Average volume | 121.12K | 27.81K |
| Shares outstanding | 7.59M | 29.94M |
| Employees | 28 | 195 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RVP has outperformed CNSY by 62.4 percentage points over the past year.
About Cerenome
CNSY stock →Cerenome, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company's lead radiotherapeutic candidate is rhenium obisbemeda, a patented radiotherapy for patients with central nervous system and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers.
Health Care · Medical/Dental Instruments · 28 employees
About Retractable Technologies
RVP stock →Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally.
Health Care · Medical/Dental Instruments · 195 employees
CNSY vs RVP FAQ
Which is bigger, Cerenome or Retractable Technologies?
Retractable Technologies (RVP) is larger, with a market capitalization of $19.85M compared with $14.65M for Cerenome (CNSY).
Which stock has performed better over the past year, CNSY or RVP?
RVP returned -28.04% over the past 12 months, compared with -90.45% for CNSY (price return, excluding dividends). Past performance does not predict future results.
Are Cerenome and Retractable Technologies in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.